Weight Loss / GLP-1

GLP-1 Weight Loss in San Diego, CA — Semaglutide & Tirzepatide Programs

GLP-1 weight loss in San Diego — physician-supervised semaglutide and tirzepatide programs with transparent pricing and ongoing medical support. By Dr. Joseph Dubroff, N.D.

GLP-1 semaglutide tirzepatide weight loss San Diego
How GLP-1 Works

A Class of Medications That Reset Hunger Itself.

GLP-1 receptor agonists are the most significant advance in medical weight loss in decades. They work by mimicking glucagon-like peptide-1 — a hormone naturally produced in your gut that signals fullness to your brain, slows gastric emptying, and improves insulin response. In patients with overweight or obesity, the GLP-1 signaling system is often dysregulated: hunger feels constant, fullness feels temporary, and the underlying metabolic machinery is calibrated against weight loss.

GLP-1 medications restore the signaling. Patients describe the effect consistently — appetite quiets, "food noise" diminishes, the constant background pull toward eating fades. Combined with a normal caloric intake, this produces sustained weight loss for most patients. Clinical trials have shown 15-22% body weight loss in well-selected patients on appropriate doses, with significant improvements in cardiovascular markers, blood pressure, blood sugar, and inflammatory markers along the way.

This is the most evidence-supported pharmaceutical intervention currently available for weight management — backed by trials with tens of thousands of patients, multiple FDA approvals across both diabetes and weight-loss indications, and continually expanding evidence on downstream cardiovascular and metabolic benefits. It's also the most appropriately-prescribed-and-misprescribed weight-loss medication of the modern era, depending entirely on who's doing the prescribing.

The Medications

Semaglutide and Tirzepatide. Same Class, Different Profiles.

Both work on the GLP-1 pathway. Tirzepatide adds a second mechanism (GIP receptor agonism) that produces stronger weight loss in clinical trials. The right choice depends on your situation.

— Medication 01

Semaglutide

Brand names: Ozempic (diabetes), Wegovy (weight loss)

The original GLP-1 medication for weight loss. Once-weekly subcutaneous injection. Clinical trials have shown roughly 15% body weight loss at the typical dose. Widely studied, well-understood side-effect profile, and the longest track record in the GLP-1 space.

Often the preferred starting point — particularly for patients sensitive to medications, those with significant GI side effects on prior medications, or those whose insurance covers semaglutide but not tirzepatide.

— Medication 02

Tirzepatide

Brand names: Mounjaro (diabetes), Zepbound (weight loss)

The newer dual-mechanism medication — combining GLP-1 receptor agonism with GIP (glucose-dependent insulinotropic polypeptide) receptor agonism. Clinical trials have shown roughly 20-22% body weight loss — meaningfully more than semaglutide for most patients.

Often the preferred choice when maximum weight-loss effect matters and the patient tolerates GLP-1 medications well. Generally a stronger appetite-suppression effect. Slightly higher cost and somewhat more potential for GI side effects, though most patients tolerate it well.

Real Medical Care vs. Telehealth Mill

What's Actually Different About How Dr. Dubroff Does This.

The GLP-1 telehealth boom has produced thousands of clinics that operate the same way: a quick form, a 10-minute video call, and the prescription gets shipped. Convenient, but the lack of real medical oversight has consequences — patients miss diagnoses that explain their weight, side effects don't get properly managed, plateaus aren't addressed, and discontinuation produces rapid rebound because the underlying drivers were never addressed.

Holistic Solutions operates differently. Here's the substantive comparison:

Holistic Solutions

Real Physician Care

  • Two-hour intake covering full medical history, weight history, hormones, gut health, and labs
  • Comprehensive lab workup including thyroid, insulin, metabolic markers, and hormones
  • Personalized protocol matching medication and dose to your physiology
  • Free follow-up calls on existing protocol — dose adjustments, side effects, plateaus
  • Active management of side effects with adjunctive strategies
  • Plateau-breaking strategies when progress stalls
  • Honest discussion of exit strategy and long-term maintenance
  • Combination therapy when warranted (MIC injections, peptides, etc.)
Typical Telehealth Mill

Prescription-Only Service

  • 10-minute video call with whoever's on duty that day
  • Form-based intake — no actual clinical assessment
  • One-size-fits-all dosing schedules regardless of your physiology
  • Side effect management often via FAQ or chat support
  • No real strategy for plateaus or stalled progress
  • No discussion of underlying drivers or hormone optimization
  • Discontinuation often produces rapid rebound — no exit plan
  • Different provider every interaction
Common Questions

GLP-1 Weight Loss FAQs

How much weight will I lose on GLP-1?+
Clinical trial averages: 15-17% body weight on semaglutide at the typical weight-loss dose, 20-22% on tirzepatide. Individual results vary significantly based on starting weight, dose, duration, lifestyle factors, and underlying physiology. Some patients exceed trial averages substantially; others fall below. Dr. Dubroff will give you a realistic expectation based on your specific situation rather than the maximum theoretical numbers.
How long does it take to start working?+
Most patients notice meaningful appetite changes within the first 1-2 weeks of starting. Initial weight loss typically begins within the first month. Significant cumulative weight loss develops over 3-12 months as the dose is titrated upward and the protocol continues. Dose escalation is structured — typically every 4 weeks — to minimize side effects while building toward the therapeutic dose.
What about side effects?+
The most common side effects are GI-related: nausea, slower digestion, occasional constipation, and reduced appetite. Most resolve as the body adjusts to the medication, typically within 1-4 weeks. Slow dose escalation minimizes these. Dr. Dubroff actively manages side effects with adjunctive strategies (hydration protocols, fiber, anti-nausea support when needed, dose timing adjustments). Less common but more serious side effects (pancreatitis, gallbladder issues) are discussed and monitored. The medications carry FDA boxed warnings related to thyroid C-cell tumors in rodent studies — these have not been definitively shown in humans but are part of the warning label and contraindicate use in patients with a personal or family history of medullary thyroid cancer or MEN-2.
Compounded versus branded — what's the difference?+
Branded medications (Wegovy, Zepbound) are produced by the original pharmaceutical manufacturers under FDA approval. Compounded semaglutide and tirzepatide are produced by licensed compounding pharmacies, typically at substantially lower cost. Quality varies significantly across compounding pharmacies — Dr. Dubroff works only with reputable licensed pharmacies that source from FDA-registered suppliers. The compounded versions allow more affordable access for patients whose insurance doesn't cover branded GLP-1 medications. Dr. Dubroff is transparent about which option fits your case.
Will the weight come back if I stop?+
Without addressing underlying drivers, weight regain is common after stopping GLP-1 — clinical research has documented this pattern. Dr. Dubroff's approach minimizes this risk by addressing what was driving the weight in the first place (hormones, insulin resistance, sleep, stress, gut, lifestyle) during the active weight-loss phase. Some patients can discontinue successfully after the active phase. Others remain on a low maintenance dose long-term for sustained metabolic and cardiovascular benefit — research increasingly supports this approach. The exit strategy is part of the protocol conversation from the start, not an afterthought.
Does insurance cover GLP-1 medications?+
Coverage is highly variable. Branded GLP-1 medications are often covered for type 2 diabetes (Ozempic, Mounjaro) but coverage for weight loss specifically (Wegovy, Zepbound) varies significantly by plan. Some plans require BMI thresholds, prior authorization, or step therapy through cheaper alternatives. Compounded versions are typically out-of-pocket. Dr. Dubroff helps you navigate coverage and find the most cost-effective path that fits your situation.
Is GLP-1 right for everyone wanting to lose weight?+
No. GLP-1 medications work well for patients with significant weight to lose, appetite-driven eating patterns, insulin resistance or pre-diabetic features, and many cardiometabolic patterns. They work less well for patients with eating patterns driven by emotional or behavioral factors that the medication doesn't address. They're not appropriate for patients with certain thyroid cancer history, active pancreatitis, severe gastroparesis, or some other specific contraindications. The free consultation is for figuring out whether GLP-1 fits — and Dr. Dubroff will tell you honestly when it doesn't.
Medical Disclaimer: Information on this page is for educational purposes and does not constitute medical advice. GLP-1 medications (semaglutide, tirzepatide) carry FDA boxed warnings related to thyroid C-cell tumors in rodent studies and are contraindicated in patients with a personal or family history of medullary thyroid cancer or MEN-2. Other contraindications include certain pancreatitis history, severe gastroparesis, and pregnancy. Compounded medications are prepared by licensed compounding pharmacies. Individual results vary, and not every patient is a candidate. Always discuss benefits and risks with a qualified healthcare provider before starting any weight-loss medication.
Get Started

Real GLP-1 Care — Not a Telehealth Refill.

Book a free consultation. Dr. Dubroff will tell you whether GLP-1 is the right tool for your case — and what an actual physician-led program looks like compared to the alternatives.